Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 961.65
+11.85 (1.25%)
Aug 21, 2026, 3:29 PM IST
Remus Pharmaceuticals Market Cap
Remus Pharmaceuticals has a market cap or net worth of 11.21 billion as of August 21, 2026. Its market cap has increased by 1.23% in one year.
Market Cap
11.21B
Enterprise Value
11.30B
Revenue
8.54B
Ranking
n/a
PE Ratio
24.54
Stock Price
961.65
ChartMarket Cap Chart
Since May 29, 2023, Remus Pharmaceuticals's market cap has increased from 2.65B to 11.21B, an increase of 323.58%. That is a compound annual growth rate of 56.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 11.21B | 36.95% |
| Dec 31, 2025 | 8.19B | -44.37% |
| Dec 31, 2024 | 14.72B | 30.53% |
| Dec 29, 2023 | 11.27B | 325.95% |
| May 29, 2023 | 2.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 14.36B |
| Infinium Pharmachem | 3.79B |
| Quest Laboratories | 1.44B |
| Sotac Pharmaceuticals | 965.77M |
| Zenith Drugs | 730.54M |
| Vilin Bio Med | 592.88M |
| Medicamen Organics | 284.31M |
| Sunrest Lifescience | 175.51M |